Valensa in a COVID-19 World

Dear Colleague: Please watch the brief video titled Valensa in a COVID-19 World in which our company addresses how Valensa assures the continuity of your business through comprehensive safety and quality protocols which have been enhanced to address the COVID-19 pandemic.  The video features and interesting conversation between our CEO and one of our production supervisors that […]

Read More »

Valensa Awarded U.S. Patent for Joint Pain Relief

The patent US10,624,919 covers a combination of hyaluronic acid and astaxanthin to alleviate joint deterioration, inflammation, and pain ORLANDO, Fla. (July 8, 2020) — The United States Patent and Trademark Office recently awarded Patent No. 10,624,919 to Florida-based Valensa International for the “Composition and Method to Alleviate Joint Pain Using Low Molecular Weight Hyaluronic Acid […]

Read More »

Prostate Health and a Standardized Lipidosterolic Extract of Saw Palmetto

Prostate Health and a Standardized Lipidosterolic Extract of Saw Palmetto By Margaret H. Dohnalek, PhD, Chief Science Officer, Valensa International Controversy exists regarding whether or not saw palmetto products support prostate health and related lower urinary tract symptoms (LUTS), such as the urge to urinate, frequent urination, and waking up at night to urinate. These […]

Read More »